Summit Securities Group’s CVS Health CVS Stock Holding History

Summit Securities Group’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-48,300	Closed	-$3.27M	–	1148
2025 Q1	$3.27M	Buy	+48,300	New	+$2.89M	0.51%	22
2022 Q2	–	Sell	-86,300	Closed	-$8.73M	–	1001
2022 Q1	$8.73M	Sell	86,300 -140,000	-62%	-$14.7M	0.98%	15
2021 Q4	$23.3M	Buy	226,300 +226,232	+332,694%	+$20.9M	1.09%	14
2021 Q3	$577K	Sell	68 -90	-57%	-$7.54K	0.04%	367
2021 Q2	$1.32M	Sell	158 -142	-47%	-$11.6K	0.11%	201
2021 Q1	$2.26M	Sell	300 -97	-24%	-$7.07K	0.25%	85
2020 Q4	$2.71M	Buy	397 +181	+84%	+$11.8K	0.23%	113
2020 Q3	$1.26M	Buy	216 +20	+10%	+$1.24K	0.13%	131
2020 Q2	$1.27M	Sell	196 -150	-43%	-$9.45K	0.16%	129
2020 Q1	$2.05M	Buy	+346	New	+$23.1K	0.36%	64
2019 Q1	–	Sell	-84	Closed	-$550K	–	228
2018 Q4	$550K	Buy	+84	New	+$6.27K	0.05%	194

Other funds holding CVS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Summit Securities Group's CVS Position: Q2 2026 in Review

Summit Securities Group reduced its CVS Health (CVS) stake by 11% in Q2 2026, selling an estimated $10.1K and leaving 896 shares worth $92.7K. The position accounts for 0.01% of the portfolio, ranked #423.

Summit Securities Group first reported a position in CVS in Q2 2013 and has held it in 39 quarters since. The position peaked at $10.1M in Q4 2021. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Summit Securities Group held 896 shares of CVS Health worth $92.7K as of Q2 2026.
Summit Securities Group sold 113 CVS Health shares in Q2 2026, an estimated $10.1K.
CVS Health made up 0.01% of Summit Securities Group's portfolio in Q2 2026, its #423 holding.
Summit Securities Group first reported a position in CVS Health in Q2 2013 and has held it in 39 quarters since.
Summit Securities Group's CVS Health position peaked at $10.1M in Q4 2021.
2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.